(Q42441010)

English

Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining

scientific article published on November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Prognosis of Japanese breast cancer based on hormone receptor and HER2 expression determined by immunohistochemical staining (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Hiroo Nakajima

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Ikuya Fujiwara

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Naruhiko Mizuta

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Koichi Sakaguchi

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Yasushi Hachimine

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Eiichi Konishi

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Akio Yanagisawa

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Junji Magae

8

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

World Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

2477-2482

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

https://scigraph.springernature.com/pub.10.1007/s00268-008-9712-8

0 references

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular portraits of human breast tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of luminal and basal cytokeratins in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-008-9712-8

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42441010&oldid=1957077294"